GlassScriptPhysician profile
Cory Ray Preuss
NPI 1588057699
$818.65
in general payments reported to CMS, 2019-2025
18 companies · $21.60 in 2025
The $21.60 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $442 · 2023: $320 · 2024: $34.98 · 2025: $21.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $143.11 | 2022-2023 | Trelegy Ellipta |
| Abbott Laboratories | $84.75 | 2022-2025 | Proclaim |
| Abbvie INC. | $83.61 | 2022-2023 | |
| Lilly USA, LLC | $64.29 | 2022-2023 | Mounjaro |
| Optinose US, INC. | $63.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.39 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $40.67 | 2023 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.26 | 2022 | |
| Revance Therapeutics, INC. | $34.98 | 2024 | Daxxify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.54 | 2022-2023 | |
| Amgen INC. | $29.71 | 2022-2023 | Prolia, Evenity |
| Si-Bone, INC. | $27.61 | 2023 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $26.68 | 2023 | |
| Novo Nordisk INC | $22.28 | 2023 | Ozempic, Rybelsus |
| Array Biopharma INC | $20.88 | 2023 | Comirnaty, Prevnar 20, Paxlovid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.97 | 2022 | |
| Exact Sciences Corporation | $19.79 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Preuss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.